Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors.
Phase of Trial: Phase I/II
Latest Information Update: 18 May 2018
At a glance
- Drugs Sonolisib (Primary) ; Docetaxel
- Indications Head and neck cancer; Non-small cell lung cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Cascadian Therapeutics
- 18 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2013 Planned end date changed from 1 Feb 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 01 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.